Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Hispanic patients in the USA have lower survival rates for melanoma compared to non-Hispanic Whites.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

Trichogerminoma is a rare, benign skin tumor from hair cells, with a small risk of becoming cancerous.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

Cells that move well may improve hair loss treatments by entering hair follicles.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Combining hair x-ray diffraction with mammography improves breast cancer detection.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

The treatment is safe and shows promise for metastatic breast cancer.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Hirsutism in women is mostly caused by polycystic ovary syndrome and idiopathic hyperandrogenism.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Boosting certain cell signals can prevent hair loss from cancer treatments.

Hair repigmentation can indicate malignancy and should be investigated.